<DOC>
	<DOCNO>NCT02774928</DOCNO>
	<brief_summary>Development pulmonary hypertension ( PH ) chronic lung diseases functional prognostic implication . PH Lung diseases usually mild moderate preserve cardiac output , evolve slowly alongside progression lung disease hypoxemia . However , minority patient develop severe PH elevation pulmonary artery pressure describe `` proportion '' underlying disease . The aim study compare characteristic outcome consecutive patient PH-due lung disease diagnose specialist referral center 1-year period .</brief_summary>
	<brief_title>Clinical Profile Patients With Pulmonary Hypertension Due Lung Diseases ( Single Center Experience )</brief_title>
	<detailed_description>Development pulmonary hypertension ( PH ) chronic lung diseases functional prognostic implication . PH Lung diseases usually mild moderate preserve cardiac output , evolve slowly alongside progression lung disease hypoxemia . However , minority patient develop severe PH elevation pulmonary artery pressure describe `` proportion '' underlying disease . Hypotheses etiology phenotype include great susceptibility alveolar hypoxia and/or tobacco smoke , destruction capillary vascular bed , inflammatory factor initiate remodel pulmonary vascular bed coexistence idiopathic pulmonary arterial hypertension ( IPAH ) patient lung disease . Severe PH-lung disease arbitrarily define rest mean pulmonary artery pressure ( PAP ) ≥35 mmHg RHC . The high increase prevalence chronic lung diseases substantial consequence develop severe PH generate increase interest PH-lung disease . Pulmonary vascular research unit Chest department Kasr-Alani school Medicine deliver regional , adult PH service population chronic lung disease . The aim study compare characteristic outcome consecutive patient PH-due lung disease diagnose specialist referral center 1-year period . Patients diagnose chronic lung disease ( COPD , ILD , OSA , Sarcoidosis ) recruit out-patient 's clinic &amp; inpatient ward Internal medicine &amp; Chest department , Kasr Al-ainy hospital ( June 2016 May 2015 ) A write informed consent match Helsinki declaration take patient . 2.2 Study method : All enrol patient go follow basically : 1 . Detailed standard Demographic &amp; clinical parameter . 2 . Assessment exercise tolerance ( 6 MWD &amp; WHO functional capacity ) 3 . Assessment pulmonary function PFTs . 4 . ECG : ( Right ventricular strain , Right axis deviation , Right bundle branch block , &amp; Left side change 0 5 . Echocardiographic evaluation PAH : ( Right atrial area , Right ventricular area , Tricuspid regurgitant jet velocity ( TR ) , Tricuspid annular plane systolic excursion ) 6 . Radiography : include chest X-ray , HRCT chest , V/Q scan &amp; CT angiography need 10 . RT side heart catheterization : - mPAP - PCWP - PVR - CARDIAC INDEX 11 . Statistical analysis : …….. The subject classify accord RHC either - Non PAH group mPAP ≤ 21mmHG - PAH mPAP≥ 25 mmHG : - Severe PH-lung disease mPAP ≥ 35 mmgh</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<criteria>1 . COPD diagnose accord Gold 2015 2 . Interstial lung diseases 3 . Obstructive Sleep Apnea 4. sarcoidosis Bronchogenic carcinoma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Pulmonary Hypertension</keyword>
	<keyword>COPD</keyword>
	<keyword>ILD</keyword>
	<keyword>OSA</keyword>
</DOC>